GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (LTS:0ACH) » Definitions » Cash Flow from Discontinued Operations

Medincell (LTS:0ACH) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Medincell Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Medincell's cash flow from discontinued operations for the six months ended in Mar. 2024 was €0.00 Mil. It means Medincell received €0.00 Mil from the sale of part of business quarterly. Medincell's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

Medincell Cash Flow from Discontinued Operations Historical Data

The historical data trend for Medincell's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Cash Flow from Discontinued Operations Chart

Medincell Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only - - - - -

Medincell Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medincell Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medincell Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Medincell's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Medincell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (LTS:0ACH) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
XPAR:AELIS XPAR:IVA XPAR:GNFT XPAR:IPH XPAR:TNG XPAR:DBV XPAR:NANO XPAR:ALSEN XPAR:ADOC XPAR:OSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
MEDCL:France MEB:Germany
Address
3 rue des Freres Lumiere, Jacou, FRA, 34830
Website
https://www.medincell.com
Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell Headlines

No Headlines